BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

ResMed Inc. (RMD) Takes Action to Enforce Patents


3/29/2013 9:44:58 AM

SAN DIEGO, March 28, 2013 /PRNewswire/ -- ResMed, an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, has filed parallel legal actions in the International Trade Commission (ITC) and in U.S. federal court to stop the infringement of ResMed patents.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

ResMed filed the actions against Taiwanese manufacturer APEX Medical and its U.S. distributor, Medical Depot, Inc., doing business as Drive Medical Design and Manufacturing. ResMed alleges that multiple ResMed patents are infringed by several APEX products, including:

  • The APEX WiZARD 210 and WiZARD 220 masks
  • The identical Freedom 210 and Freedom 220 masks made by APEX and sold by Medical Depot
  • The APEX iCH and XT Fit flow generators

ResMed is asking the ITC to stop the importation and sales of these products in the United States, and it is asking the U.S. federal court to stop the infringement and award damages against the defendants.

"For more than two decades, ResMed has generated significant advances in innovative products for sleep-disordered breathing therapy," said ResMed global general counsel and chief administrative officer David Pendarvis. "We invest over a hundred million dollars in research and development each year to fuel these advances and other companies should not be allowed to infringe ResMed's intellectual property by using our technology."

About ResMed:
ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.

Contacts:




For News Media

For the Finance and Investor Community

Gretchen Griswold

Constance Bienfait

Director, Global Corporate Communications

Director, Investor Relations

O: 858-836-6789

O: 858-836-5971

news@resmed.com

constance.bienfait@resmed.com

SOURCE ResMed Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->